Recalls / —
—#175626
Product
Siemens Atellica CH 930 Analyzer. Siemens Material Number (SMN): 11067000 Product Usage: automated, clinical chemistry analyzer to perform in vitro diagnostic tests on clinical specimens
- FDA product code
- JGS — Electrode, Ion Specific, Sodium
- Device class
- Class 2
- Medical specialty
- Clinical Chemistry
- 510(k) numbers
- K151767
- Affected lot / code info
- Software version: V1.19.2 and below
Why it was recalled
Atellica CH 930 Analyzer - Erroneous Indices for Hemolysis and Lipemia in Software versions 1.19.2 and below
Root cause (FDA determination)
Software design
Action the firm took
Siemens issued an Urgent medical Device Correction, (UMDC ASI19-02.A.US) via Fed Ex and Urgent Field Safety Notification (UFSN ASI19-02.A.OUS) to all affected Customers beginning on 2019-07-30. The UFSN/UMDC explain the behaviors that can occur and instructs customers on actions to be taken for the issues described in the communication. Customers are requested to return the attached effectiveness check form via fax or email within 30 days. Field Service personnel will be sent a Service Knowledge Base describing the issue and instructing them how to deal with customer questions.
Recalling firm
- Firm
- Siemens Healthcare Diagnostics, Inc.
- Address
- 511 Benedict Ave, Tarrytown, New York 10591-5005
Distribution
- Distribution pattern
- Worldwide Distribution - US Nationwide Foreign: Argentina Australia Austria Bangladesh Belgium Brazil Bulgaria Canada Chile Colombia Czech Republic Denmark Ecuador Egypt Finland France Germany Greece Hungary India Indonesia Iran Ireland Israel Italy Japan Kuwait Latvia Malaysia Mexico Netherlands Nigeria Norway P.R. China Pakistan Philippines Poland Portugal Qatar Republic Korea Romania Russian Fed. Saudi Arabia Singapore Slovakia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey U.A.E. United Kingdom Uruguay Vietnam
Timeline
- Recall initiated
- 2019-07-30
- Terminated
- 2022-06-10
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #175626. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.